Fecal microbiota transplantation as a mean of overcoming immunotherapy-resistant cancers - hype or hope?

Ther Adv Med Oncol. 2021 Sep 28:13:17588359211045853. doi: 10.1177/17588359211045853. eCollection 2021.

Authors

Erez N Baruch¹, Tanmay Gaglani¹, Jennifer A Wargo²

Affiliations

¹ Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX, USA.
² Program for Innovative Microbiome and Translational Research, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, FCT17.6060, Unit 1484, Houston, TX 77030, USA.

No abstract available

Keywords: anti-PD-1; checkpoint inhibitors; fecal microbiota transplantation; immunotherapy; melanoma; microbiome.

Publication types

Editorial